Masimo (NASDAQ:MASI) Reaches New 12-Month Low – What’s Next?

Masimo Corporation (NASDAQ:MASIGet Free Report) shares hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $131.43 and last traded at $131.3680, with a volume of 69156 shares changing hands. The stock had previously closed at $132.76.

Analyst Ratings Changes

Several brokerages have commented on MASI. BTIG Research raised their price target on shares of Masimo from $198.00 to $200.00 and gave the company a “buy” rating in a research report on Thursday, December 4th. Bank of America assumed coverage on Masimo in a research report on Monday, November 17th. They set a “neutral” rating and a $162.00 price objective for the company. Wall Street Zen upgraded shares of Masimo from a “hold” rating to a “buy” rating in a research note on Tuesday, October 14th. Wells Fargo & Company reiterated an “overweight” rating and issued a $190.00 price target on shares of Masimo in a research note on Friday, December 5th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Masimo in a report on Wednesday, October 8th. Four research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $189.40.

View Our Latest Research Report on Masimo

Masimo Price Performance

The stock has a market capitalization of $7.05 billion, a price-to-earnings ratio of -12.46, a price-to-earnings-growth ratio of 1.44 and a beta of 1.26. The company has a current ratio of 2.84, a quick ratio of 1.92 and a debt-to-equity ratio of 0.69. The company’s 50 day moving average is $142.56 and its 200 day moving average is $149.27.

Masimo (NASDAQ:MASIGet Free Report) last issued its quarterly earnings data on Thursday, June 20th. The medical equipment provider reported $1.42 earnings per share (EPS) for the quarter. Masimo had a positive return on equity of 33.04% and a negative net margin of 33.20%.The company had revenue of $617.00 million for the quarter. Research analysts anticipate that Masimo Corporation will post 4.1 EPS for the current fiscal year.

Hedge Funds Weigh In On Masimo

A number of institutional investors have recently modified their holdings of the business. Durable Capital Partners LP acquired a new position in Masimo in the first quarter valued at $187,528,000. Viking Global Investors LP acquired a new position in Masimo in the 2nd quarter valued at about $129,096,000. Squarepoint Ops LLC raised its stake in Masimo by 738.8% during the 3rd quarter. Squarepoint Ops LLC now owns 620,932 shares of the medical equipment provider’s stock valued at $91,619,000 after acquiring an additional 546,905 shares during the last quarter. Westfield Capital Management Co. LP lifted its position in Masimo by 75.9% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,181,203 shares of the medical equipment provider’s stock worth $198,702,000 after acquiring an additional 509,724 shares during the period. Finally, Massachusetts Financial Services Co. MA grew its stake in shares of Masimo by 25.5% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 2,470,393 shares of the medical equipment provider’s stock valued at $415,570,000 after purchasing an additional 502,555 shares during the last quarter. 85.96% of the stock is owned by institutional investors and hedge funds.

About Masimo

(Get Free Report)

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Recommended Stories

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.